SEARCH Articles Figures Tables A Systems Biology Approach to Target Identification and Validation for Human Chronic Disease Drug Discovery Acid-peptic disease drugs used Adverse drug reactions allergic diseases Adverse drug reactions concurrent diseases Adverse drug reactions hepatic disease Adverse drug reactions liver disease Adverse drug reactions renal disease Adverse, drug reactions diseases, influence Alzheimer disease drug therapy Anticholinergic drugs Parkinson disease Antidepressant drugs cardiac disease Antidepressant drugs cardiovascular disease Antidepressant drugs psychiatric disease Antirheumatics disease-modifying drugs Autocoids Drugs Used for Inflammatory-Related Diseases Autoimmune diseases drugs Bone disease drugs Cardiovascular disease drug therapy Chronic disease, oral drug absorption Chronic kidney disease drug dosing Chronic obstructive pulmonary disease drug development Chronic obstructive pulmonary disease drug therapy Course of Parkinson Disease When to Use Specific Drugs Digoxin drug-disease interactions Disease adverse drug interactions Disease drug-induced Disease modifying anti-rheumatic drugs DMARDs) Disease modifying antirheumatic drugs DMARDs) Disease-directed designer drugs Disease-modifying Anti-rheumatic Drugs Disease-modifying antirheumatic drugs Disease-modifying antirheumatic drugs, in rheumatoid Disease-modifying antirheumatic drugs, in rheumatoid arthritis Disease-modifying drugs Diseases, tropical drug-resistant Drug Transporters in Health and Disease Drug Treatment of Parkinsons Disease Drug absorption, pharmacokinetic renal disease Drug delivery dental diseases Drug discovery disease-related Drug discovery validated disease target Drug distribution , volume hepatic disease Drug distribution , volume renal disease Drug metabolism, pharmacokinetic hepatic disease Drug metabolism, pharmacokinetic renal disease Drug-disease interactions Drug-induced autoimmune disease Drug-induced autoimmune disease autoimmunity Drug-induced autoimmune disease mechanisms Drug-induced gastric disease Drug-induced lung disease Drug-induced pulmonary disease Drug-induced renal disease Drugs for Alzheimer’s disease Drugs for Neglected Diseases Initiative Drugs for Neglected Diseases Initiative DNDi) Drugs heart disease Drugs human diseases Drugs respiratory diseases Drugs used in Parkinsons disease Drugs used to treat Parkinsons disease Drugs used to treat rheumatic diseases Effects of Renal Disease on Drug Absorption Food-drug interactions liver disease Glomerular disease drug-induced Heart disease cardiac drugs Heart disease drug-related Hepatic disease altered drug metabolism Hepatic disease drug metabolism Hepatic disease drug-induced Herbal Drugs and Their High Demand in Treating Diseases How Drugs Work Disease Prevention Hydatid disease , drugs Kidney disease, drug-induced Kidney disease, drug-induced prevention Liver disease altered drug metabolism Liver disease drug metabolism Liver disease drug treatment Liver disease drug-induced Liver disease drug-related Liver disease drugs Liver disease, drug contraindications Liver drug-induced disease/damage Lung disease drug deposition Lymphoid disease, drug-induced Medicines, Prescription Drugs, and Diseases The Top Tens Mental disease drugs Mental diseases, drug treatment Multi-target drugs disease Nanotechnology-controlled drug delivery for treating bone diseases Nonsteroidal anti-inflammatory drugs disease Nonsteroidal anti-inflammatory drugs diseases treated Older people drug-disease interactions Osteoarthritis disease-modifying drugs Parkinson disease antimuscarinic drugs Parkinson’s disease drug-induced Peptic ulcer disease drug-induced Peptic ulcer disease drugs used Periodontal disease drugs Pharmacokinetics of drugs in liver disease Pulmonary drug delivery systemic diseases Renal disease drug elimination Renal disease drug-related Renal disease, drug contraindications Rheumatic disease antirheumatic drugs Rheumatoid arthritis disease-modifying antirheumatic drugs Subcutaneous drugs renal disease The Drugs for Neglected Diseases initiative The Drugs for Neglected Diseases initiative DNDi) Tropical diseases drug development Tubulointerstitial disease drug-induced Use of drugs in disease states Veno-occlusive disease drug-induced Wasting disease drugs